BEAM Alliance

Driving Innovation, Shaping Policy:
Europe’s SMEs United Against AMR

BEAM at work

Our advocacy work is based on analysis and reflection with our members.
Each topic is dealt with by a task force, which acts as a discussion platform and issues policy briefs.

PULL incentives
PUSH incentives
Diagnostics
Prevention

Evaluation
Phages
National actions
BEAM papers

Members

Latest news

1 July 2026

Telum Therapeutics Secures €18 Million Series A Financing to Advance Lead Antimicrobial Program into Clinical Development

The investment from AMR Action Fund, the world’s largest venture capital fund dedicated exclusively to investing in urgently needed antimicrobial…

30 June 2026

REVIVE Webinar: Targeting metabolism in mycobacteria to develop new antimicrobials

This webinar will explore the promising strategy of studying and targeting the metabolism of this microorganism in order to develop…

30 June 2026

Broad multidisciplinary coalition warns AMR threatens global health security and urges G7 leaders to make it a public health priority

A new international coalition of more than 60 experts and organisations is calling on G7 leaders to urgently take action…

All the news

Legal notice | Photo credits

Who we are
Overview
Members
Pipeline
News

Connect with us

contact@beam-alliance.eu
29 Avenue Tony Garnier 69007 Lyon - France